T cell Lymphoma re-evaluation after NED

Your husband’s re-evaluation is a standard VA process to determine if his current condition warrants a continuation of his 100% rating, as his temporary total rating was predicated on active treatment and severe symptoms, and he is now two years post-treatment with No Evidence of Disease (NED). Under **38 CFR 3.105(e)**, the VA may propose to reduce a disability rating if evidence shows material improvement in the service-connected condition. For residuals of lymphoma, the VA will evaluate under **38 CFR 4.117**, Diagnostic Code (DC) **7715** (Neoplasm, malignant, any specified part of the lymphatic system), which mandates a 100% rating for active malignancy or while undergoing treatment, but requires a rating based on residual disabilities (e.g., chronic weakness, neurological issues, or chemotherapy-induced peripheral neuropathy) post-treatment. The evaluation must consider the **DeLuca v. Brown** principles, assessing the veteran's ability to function under ordinary conditions of life and work, not just clinical remission. Actionable next steps are to meticulously prepare for the VES exam by gathering all post-treatment medical records detailing any lingering symptoms, functional impairments, and physician statements on prognosis; these residuals should be claimed as secondary conditions if not already service-connected. It is critical to argue that a reduction is not warranted if residuals collectively cause significant impairment, potentially still supporting a 100% rating via scheduler or extrascheduler means if they equate to total occupational and social impairment per **38 CFR 4.130** (DC 9400 for mental health impacts, if applicable).

*Disclaimer: This information is for educational purposes regarding VA claims processes and is not intended as legal or medical advice. For personal guidance, consult with an accredited VA attorney or claims agent.*